Importantly, the Mcl-1 locus was shown to be recurrently amplified across multiple tumor types (∼10%) in a large-scale cancer genome study (Beroukhim et al., 2010), and Mcl-1 was found to be highly expressed across a panel of 729 human cancer cell lines (Wei et al., 2012). This evidence concerns the gene MCL1 and cancer.